Alert detail

LCD L36761: GlycoMark® Testing for Glycemic Control — Palmetto GBA

Policy ID: LCD-L36761Specialty: EndocrinologyAdded: 9/12/2026Effective: July 27, 2023lcd
Low

What changed

Palmetto GBA finalizes GlycoMark® glycemic control testing coverage criteria.

Who’s affected: Endocrinology billing teams · Effective: July 27, 2023

Affected codes

Codes82985

Primary source: View the official CMS/MAC document ↗

Get the action steps and full analysis

This change affects 6 billing codes.

The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.